Literature DB >> 816263

Successful arterial substitution with modified human umbilical vein.

H Dardik, I I Dardik.   

Abstract

Human umbilical veins were prepared as vascular grafts by tanning with dialdehyde starch or gluteraldehyde and by structural re-inforcement with an outer polyester fiber mesh. These grafts were implanted in baboons in the aortoiliac position for periods of 3 days to 9 months. There was no aneurysm formation and there was an excellent maintenance of patency as well as function. Histologic evaluation of the graft materials showed a dense collagen layer within the encircling polyester fiber mesh. A multicellular subintimal layer formed a discrete inner capsule. The inflammatory response with the umbilical component was insignificant. There was no evidence of rejection. This study suggests that the modified umbilical vein can serve as a satisfactory blood conduit. Experience with three short-term clinical implants supports the applicability and potential for this new vascular graft.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 816263      PMCID: PMC1344232          DOI: 10.1097/00000658-197603000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  11 in total

1.  Late occlusion of femoral and popliteal fabric arterial grafts.

Authors:  W S EDWARDS
Journal:  Surg Gynecol Obstet       Date:  1960-06

2.  Femoropopliteal composite dacron and autogenous vein bypass grafts. A preliminary report.

Authors:  R R Linton; L S Wirthlin
Journal:  Arch Surg       Date:  1973-11

3.  Future directions in the development of arterial prostheses for small and medium caliber arteries.

Authors:  L R Sauvage; K E Berger; P B Mansfield; S J Wood; J C Smith; J B Overton
Journal:  Surg Clin North Am       Date:  1974-02       Impact factor: 2.741

4.  Silicone mandril method for growing reinforced autogenous femoro-popliteal artery grafts in situ.

Authors:  C H Sparks
Journal:  Ann Surg       Date:  1973-03       Impact factor: 12.969

5.  Antigenicity of vascular heterografts.

Authors:  S P Mattila; T J Fogarty
Journal:  J Surg Res       Date:  1973-08       Impact factor: 2.192

6.  Clinical experience with preserved human allografts for vascular reconstruction.

Authors:  D A Tice; V Zerbino
Journal:  Surgery       Date:  1972-08       Impact factor: 3.982

7.  Prolonged survival of glutaraldehyde-treated skin homografts.

Authors:  I Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

8.  Experiences with modified bovine carotid arteries in arterial surgery.

Authors:  D M Rosenberg; B A Glass; N Rosenberg; M R Lewis; W A Dale
Journal:  Surgery       Date:  1970-12       Impact factor: 3.982

9.  The fate of human umbilical cord vessels used as interposition arterial grafts in the baboon.

Authors:  I I Dardik; H Dardik
Journal:  Surg Gynecol Obstet       Date:  1975-04

10.  Vascular heterograft: human umbilical cord vein as an aortic substitute in baboon. A preliminary report.

Authors:  I Dardik; H Darkik
Journal:  J Med Primatol       Date:  1973       Impact factor: 0.667

View more
  14 in total

1.  FEMORAL POPLITEAL BYPASS EMPLOYING MODIFIED HUMAN UMBILICAL CORD VEIN: AN ASSESSMENT OF EARLY CLINICAL RESULTS.

Authors:  Irving Dardik; Ibrahim Ibrahim; Herbert Dardik
Journal:  Cardiovasc Dis       Date:  1976

Review 2.  Human Perinatal-Derived Biomaterials.

Authors:  Marc C Moore; Aurore Van De Walle; Jerry Chang; Cassandra Juran; Peter S McFetridge
Journal:  Adv Healthc Mater       Date:  2017-08-07       Impact factor: 9.933

3.  Experimental studies on arterial reconstruction with bovine pericardial tube.

Authors:  B G Zhang; X F Chen
Journal:  Acta Acad Med Wuhan       Date:  1982

4.  The use of stabilized human umbilical vein for femoropopliteal bypass. Experience with 133 operations with 5-year follow-up.

Authors:  S A Hirsch; F Jarrett
Journal:  Ann Surg       Date:  1984-08       Impact factor: 12.969

5.  The consequence of biologic graft processing on blood interface biocompatibility and mechanics.

Authors:  Aurore B Van de Walle; Joseph S Uzarski; Peter S McFetridge
Journal:  Cardiovasc Eng Technol       Date:  2015-09       Impact factor: 2.495

6.  Biodegradation and aneurysm formation in umbilical vein grafts. Observations and a realistic strategy.

Authors:  H Dardik; I M Ibrahim; B Sussman; M Kahn; M Sanchez; S Klausner; R E Baier; A E Meyer; I I Dardik
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

7.  Modified vein allograft for small arterial reconstruction in dogs.

Authors:  Y Muto; H Eguchi; T Miyazaki; T Yukizane; K Okadome; K Sugimachi
Journal:  Jpn J Surg       Date:  1986-05

8.  Development of decellularized human umbilical arteries as small-diameter vascular grafts.

Authors:  Liqiong Gui; Akihito Muto; Stephen A Chan; Christopher K Breuer; Laura E Niklason
Journal:  Tissue Eng Part A       Date:  2009-09       Impact factor: 3.845

9.  Human umbilical veins and autogenous veins as canine arterial bypass grafts.

Authors:  R W Oblath; F O Buckley; W A Donnelly; R M Green; J A Deweese
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

10.  Modified human umbilical vein graft arteriovenous fistulae as a source of angioaccess in maintenance hemodialysis.

Authors:  Pedro A. Rubio; Edward M. Farrell
Journal:  Cardiovasc Dis       Date:  1980-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.